Metraipolis › archive › dc_bbd2b72010b2

Long-Acting Recombinant IL-7 (rhIL-7-hyFc) Enhances the Primary and Memory Neoantigen-Specific Immune Response to Breast Cancer Personalized Cancer Vaccines — Europe PMC PMID:41097705

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41097705
DOI
10.3390/cancers17193177
License (as archived)
solo-consultazione
Archived
2026-11-09T15:14:06.200Z
SHA-256 of the archived text
9ebc1fc393960234f05cffea820d1b8ead07b31c7888ba0d112b76b65e120d25
Stable URL of this page
https://metraipolis.com/documento/dc_bbd2b72010b2

How to cite

Long-Acting Recombinant IL-7 (rhIL-7-hyFc) Enhances the Primary and Memory Neoantigen-Specific Immune Response to Breast Cancer Personalized Cancer Vaccines — Europe PMC PMID:41097705 — Europe PMC (en), https://europepmc.org/article/MED/41097705 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bbd2b72010b2 (Metraipolis archive dc_bbd2b72010b2, sha256 9ebc1fc393960234f05cffea820d1b8ead07b31c7888ba0d112b76b65e120d25)
BibTeX
@misc{dcbbd2b72010b2,
  title = {Long-Acting Recombinant IL-7 (rhIL-7-hyFc) Enhances the Primary and Memory Neoantigen-Specific Immune Response to Breast Cancer Personalized Cancer Vaccines — Europe PMC PMID:41097705},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41097705},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bbd2b72010b2; sha256 9ebc1fc393960234f05cffea820d1b8ead07b31c7888ba0d112b76b65e120d25},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41097705. Agents can read the archived copy with the MCP tool read_document.